Abstract Immunotherapy is a rapidly expanding field in contemporary oncology with clinical trials in multiple disease sites demonstrating improved survival outcomes for advanced cancers. The efficacy of these targeted agents as oncologic treatments is derived from an immune-targeted antitumoral response; however, this immune upregulation can also cause significant inflammatory and autoimmune side-effects. As a result,...
Pro zobrazení tohoto obsahu je třeba být přihlášen.